A retrospective study to evaluate the efficacy of Sofosbuvir based regimens in patients with hepatitis C virus infection

Trial Profile

A retrospective study to evaluate the efficacy of Sofosbuvir based regimens in patients with hepatitis C virus infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 May 2016

At a glance

  • Drugs Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2016 New trial record
    • 17 Apr 2016 Results (n=522) assessing the association between week 4 HCV RNA and SVR were presented at The International Liver Congress™ 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top